Obviously, the shift from the ErbB pathway to MAPK pathway (due to different epigenetic miRNA regulation and methylation), triggering changes in the cell responses via different TFs, may be the main mechanism of progression from stage I to stage II HCC. The gene discussed is EGFR; the disease is hepatocellular carcinoma.